A £50,000 grant will help to develop an innovative new device to support people with reduced mobility to remain in their own homes.
iCare Technology, based at the Liverpool Innovation Park, has received Pathfinder investment from The North West Fund for Biomedical, which is managed by SPARK Impact.
The money will be used to further develop the Mylinqs eco system, which works by connecting a wireless, big-button touch keyboard to a television set to provide communication services, care monitoring and health and wellbeing services to people in their own homes.
Medwyn Jones, chief executive of iCare, said: “Allowing older or disabled people to extend their time living at home is a crucial central government initiative which our technology aims to support.
“The investment from SPARK Impact will enable us to pursue a number of existing opportunities in the health and wellbeing sector while also strengthening our core proposition and extending our partner relationships.”
Dr Penny Attridge, senior investment director at SPARK Impact and manager of The North West Fund for Biomedical, added: “The iCare technology could be a real breakthrough for assisted independent living, transforming the quality of life for thousands of people. We are pleased to support their efforts and look forward to helping Mylinqs reach the market.”
iCare is The North West Fund for Biomedical’s 35th investment to date.
